Watch the Patient-Focused Drug Development Meeting
That Took Place September 9, 2021
The U.S. Food and Drug Administration (FDA) heard from more than 40 food allergy patients and caretakers describing the challenges of living with food allergies as part of a day-long hybrid Externally-led Patient Focused Drug Development (EL-PFDD) meeting held September 9. 2021.
Want to watch it Click here.